Results 201 to 210 of about 3,092 (251)
On RNA-programmable gene modulation as a versatile set of principles targeting muscular dystrophies. [PDF]
Mol TherCapelletti S +2 more
europepmc +1 more source
A Neonatal Case of Hemorrhagic Shock Due to Congenital Hemangioma. [PDF]
CureusKudo M +4 more
europepmc +1 more source
Merosin-deficient congenital muscular dystrophy in Korea
Brain and Development, 2009 Congenital muscular dystrophy (CMD) is a clinically and genetically heterogeneous group of muscle disorders, presenting at birth or early infancy with hypotonia, muscle weakness, joint contractures, and dystrophic changes in the muscles. Merosin-deficient CMD (MDCMD) is rare in Asian populations, but more common in Caucasians, comprising about 50% of ...
Jong-Hee, Chae +9 more
openaire +4 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Severe classical congenital muscular dystrophy and merosin expression
Clinical Genetics, 1998Vajsar J, Chitayat D, Becker LE, Ho M, Ben‐Zeev B, Jay V. Severe classical congenital muscular dystrophy and merosin expression. Clin Genet 1998: 54: 193–198. 0 Munksgaard, 1998It has been suggested that patients with autosomal recessive merosin deficient congenital muscular dystrophy (CMD), as opposed to the merosin positive cases form a homogeneous ...
Jiří Vajsar +2 more
exaly +3 more sources
Prenatal Detection of Merosin Expression in Human Placenta
Neuropediatrics, 1994F M Tome
exaly +3 more sources
Merosin and congenital muscular dystrophy
Microscopy Research and Technique, 2000Merosin (also called as Laminin-2) is an isoform of laminin comprised of the alpha2, beta1 and gamma1 chains. In European populations, half of the patients with classical congenital muscular dystrophy have mutations of the LAMA2 gene (6q22-23) and present reduced or absence of laminin alpha2 chain.
Y, Miyagoe-Suzuki +2 more
openaire +2 more sources